Tikun Olam Europe pioneers by conducting the first export of completed Medical Hashish merchandise to Switzerland.
In a landmark second for the Greek medical hashish business, Tikun Olam Europe, the first Medical Hashish Firm in Greece, units new requirements and achieves one other first by finishing the first export of completed medical hashish merchandise from Greece. This milestone marks the launch of its operations in worldwide markets, with Switzerland because the vacation spot, in collaboration with the Swiss pharmaceutical firm MediCrops AG.
This groundbreaking step underscores Greece’s potential to emerge as a key hub for the European and world medical hashish market, bolstering its place as a global producer of high-quality completed medical hashish merchandise.
Tikun Olam Europe owns state-of-the-art amenities in Corinth, licensed based on the stringent EU-GMP (Good Manufacturing Practices) and GACP (Good Agricultural and Assortment Practices) requirements. These certifications, granted by the Nationwide Group for Medicines (EOF) and Q-CERT respectively, affirm the corporate’s dedication to excellence at each stage of manufacturing.
The first export to Switzerland consists of completed medical hashish merchandise in dried flower type, cultivated from hashish strains developed with superior scientific practices underneath the signature of Tikun Olam. These identical strains are used to supply the completed medical hashish merchandise already out there within the Greek market, delivering modern options to the therapeutic group.
Strategically, Tikun Olam Europe invests in increasing its export portfolio, setting as subsequent purpose, to incorporate merchandise within the type of sublingual oil drops, enhancing the therapeutic choices out there to sufferers.
Furthermore, Tikun Olam Europe plans to increase exports to key European medical hashish markets, resembling the UK and Germany—strategic areas anticipated to considerably contribute to the corporate’s progress at a European stage.
Mr. Nikos Beis, CEO of Tikun Olam Europe, remarked, “Our 1st export represents a historic milestone, not just for Tikun Olam Europe but in addition for our nation. It demonstrates that Greece can lead in worldwide markets with modern medical hashish merchandise manufactured underneath the very best security and high quality requirements.” He added, “Our export exercise to Switzerland in collaboration with MediCrops AG -an modern pharmaceutical firm, dedicated to cutting-edge solutions- aligns completely with our values. Collectively, we intention to ship completed medical hashish merchandise made to the very best requirements to enhance sufferers’ high quality of life. This marks solely the start of a strategic improvement plan that may strengthen Tikun Olam Europe’s place within the world medical hashish worth chain.”
Mr. Ivan Mestrangelo, Chairman, MediCrops AG, said “We’re proud to collaborate with Tikun Olam Europe, a pioneer in evidence-based medical hashish. This partnership is a game-changer for the Swiss market, the place we’re dedicated to advancing affected person entry to high-quality cannabis-based remedies. The combination of Tikun Olam’s scientifically validated merchandise into our complete distribution community, which incorporates our personal telemedicine platform (Enmedify), licensed pharmacy, and devoted hashish therapy clinics, ensures that Swiss sufferers obtain the very best normal of care. Collectively, we’re shaping the way forward for medical hashish in Switzerland, delivering accessible, evidence-driven therapies that rework affected person outcomes. This partnership not solely helps the expansion of the Swiss market but in addition units a benchmark for the accountable use of hashish in healthcare.”
